Cargando...
AB007. Protein therapy to regenerate erectile tissue for future management of erectile dysfunction
Oral phosphodiesterase type 5 inhibitor, including sildenafil citrate, are well utilized as first-line therapy because those are effective and convenient for the majority of erectile dysfunction (ED) patients. However, there is a need for increased treatment efficacy for patients with ED. These oral...
Gardado en:
| Publicado en: | Transl Androl Urol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AME Publishing Company
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6186680/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2018.AB007 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|